Published in Clin Transplant on November 02, 2010
Current diagnosis and treatment of benign biliary strictures after living donor liver transplantation. World J Gastroenterol (2016) 0.81
Management of Biliary Strictures After Liver Transplantation. Gastroenterol Hepatol (N Y) (2015) 0.78
Endoscopic management of biliary strictures after living donor liver transplantation. Clin J Gastroenterol (2017) 0.75
Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function. N Engl J Med (2015) 5.12
Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology (2008) 4.26
Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl (2014) 3.11
New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology (2013) 2.76
Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64
Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology (2005) 2.63
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl (2005) 2.56
A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation (2006) 2.55
Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2008) 2.30
Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl (2002) 2.28
Improving liver allocation: MELD and PELD. Am J Transplant (2004) 2.14
Developmental context determines latency of MYC-induced tumorigenesis. PLoS Biol (2004) 2.05
Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl (2002) 2.03
Incidence of death and potentially life-threatening near-miss events in living donor hepatic lobectomy: a world-wide survey. Liver Transpl (2013) 2.00
Donor morbidity after living donation for liver transplantation. Gastroenterology (2008) 1.90
The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant (2005) 1.90
Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest (2002) 1.80
Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant (2003) 1.65
Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med (2008) 1.61
Predictors associated with terminal renal function in deceased organ donors in the intensive care unit. Anesthesiology (2009) 1.60
Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation (2003) 1.54
Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation. Am J Cardiol (2009) 1.53
Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus. Liver Transpl (2011) 1.52
Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010. Arch Surg (2011) 1.51
Use of CT cholangiography to evaluate the biliary tract after liver transplantation: initial experience. Liver Transpl (2004) 1.50
Liver regeneration and surgical outcome in donors of right-lobe liver grafts. Transplantation (2003) 1.49
Expanding the donor pool: can the Spanish model work in the United States? Am J Transplant (2003) 1.48
Factors influencing liver transplant length of stay at two large-volume transplant centers. Liver Transpl (2009) 1.48
Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial. Liver Transpl (2013) 1.46
Trends over a decade of pediatric liver transplantation in the United States. Liver Transpl (2006) 1.45
Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant (2002) 1.44
Offer patterns of nationally placed livers by donation service area. Liver Transpl (2013) 1.42
Long-term outcomes and late complications of laparoscopic nephrectomy with renal autotransplantation. J Urol (2007) 1.39
H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney Int (2005) 1.38
Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA (2012) 1.33
A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl (2003) 1.25
Accuracy of plain abdominal radiographs in the detection of retained surgical needles in the peritoneal cavity. Ann Surg (2008) 1.24
Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg (2010) 1.22
Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin. Liver Transpl (2009) 1.20
Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl (2004) 1.19
Living donor liver transplantation in adults: vascular variants important in surgical planning for donors and recipients. AJR Am J Roentgenol (2003) 1.17
Metabolic profiling of livers and blood from obese Zucker rats. J Hepatol (2005) 1.16
Expanded experience with laparoscopic nephrectomy and autotransplantation for severe ureteral injury. J Urol (2003) 1.16
More than 500 consecutive laparoscopic donor nephrectomies without conversion or repeated surgery. Arch Surg (2005) 1.13
Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis (2008) 1.12
A randomized trial of exercise training after renal transplantation. Transplantation (2002) 1.12
Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and review. J Gastrointest Surg (2010) 1.12
New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl (2004) 1.11
Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome. Liver Transpl (2010) 1.11
Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival. Liver Transpl (2009) 1.10
Living donor adult liver transplantation: a longitudinal study of the donor's quality of life. Am J Transplant (2005) 1.09
Split-liver transplantation in the United States: outcomes of a national survey. Ann Surg (2004) 1.08
Laparoscopic procurement of kidneys with multiple renal arteries is associated with increased ureteral complications in the recipient. Am J Transplant (2005) 1.08
Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl (2011) 1.08
Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. Am J Transplant (2005) 1.06
Long-term renal function and cardiovascular disease risk in obese kidney donors. Clin J Am Soc Nephrol (2009) 1.04
Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Liver Transpl (2004) 1.01
End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation. J Urol (2005) 1.00
De novo malignancies following liver transplantation: a case-control study with long-term follow-up. Clin Transplant (2006) 0.99
Race and sex disparities in liver transplantation: progress toward achieving equal access? JAMA (2008) 0.99
Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma. Clin Transplant (2012) 0.99
Biliary tract depiction in living potential liver donors: comparison of conventional MR, mangafodipir trisodium-enhanced excretory MR, and multi-detector row CT cholangiography--initial experience. Radiology (2004) 0.98
A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl (2011) 0.97
Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation. Transplantation (2008) 0.97
Left hepatectomy versus right hepatectomy for living donor liver transplantation: shifting the risk from the donor to the recipient. Liver Transpl (2013) 0.96
Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology (2004) 0.96
Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation. Liver Transpl (2013) 0.95
Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation. Hum Pathol (2002) 0.95
Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study. Hum Pathol (2003) 0.94
BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant. Am J Transplant (2005) 0.93
Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation. Liver Transpl (2012) 0.93